Fmoc-L-aspartic acid α-allyl ester

Fmoc-L-aspartic acid α-allyl ester is an Fmoc-protected L-aspartate derivative in which the α-carboxyl group is present as an allyl ester while the side-chain carboxylic acid remains available for orthogonal protection or selective functionalization. The molecule combines an aromatic Fmoc carbamate for temporary amine masking, an L-aspartate stereocenter that governs peptide stereochemistry, and an allyl ester handle that can be removed under allyl-cleaving conditions to regenerate the free α-carboxyl group. The side-chain carboxyl functionality enables controlled formation of peptide bonds or conversion into amide, ester, or activated acid intermediates, supporting downstream aspartyl motif construction. The resulting protected amino acid ester participates in standard peptide coupling workflows while also serving as a chemically addressable intermediate for orthogonal deprotection and side-chain elaboration.

1. Peptide Synthesis

Fmoc-L-aspartic acid α-allyl ester supports stepwise solid-phase or solution-phase peptide assembly through its Fmoc-protected amino group, which enables iterative N-terminal deprotection and coupling while maintaining L-configuration at the α-carbon. The allyl ester at the α-position can be used as an orthogonal carboxyl protection strategy, allowing selective deprotection to generate the reactive acid for subsequent coupling or for conversion into activated derivatives. The side-chain carboxyl group characteristic of aspartate can be protected or activated to control whether the peptide linkage forms at the backbone position only or also enables side-chain functionalization. Downstream peptide building block preparation and aspartyl-containing sequence construction can be carried out with compatibility to common peptide coupling chemistries and orthogonal protection schemes used in peptide science.

2. Side-Chain Functionalization

Fmoc-L-aspartic acid α-allyl ester is applicable to synthetic organic chemistry workflows that require controlled manipulation of the aspartate side-chain carboxyl group while preserving an orthogonally protected α-carboxyl function. The combination of an allyl ester and an Fmoc carbamate provides two chemically distinct handles, enabling staged deprotection and conversion into amides, esters, or activated acids that can be used to introduce functional groups at the side chain. The L-aspartate stereochemistry can be retained during derivatization, supporting stereodefined analog synthesis for peptidomimetic scaffolds. The allyl ester can also serve as a temporary protection element during multi-step syntheses that culminate in targeted side-chain elaboration for structure-guided molecular design.

3. Peptidomimetics And SAR Studies

Fmoc-L-aspartic acid α-allyl ester can be employed in medicinal chemistry-oriented synthesis of peptidomimetics and amino acid analogs used for structure-activity relationship studies. The aspartate motif contributes a stereodefined acidic side chain that can be transformed into amide-linked surrogates, esterified variants, or other carboxyl-derived functionalities that modulate hydrogen-bonding and ionization behavior in binding studies. The Fmoc group enables incorporation into peptide-like frameworks where controlled N-terminal presentation is required, while the allyl ester provides an orthogonal strategy to adjust which carboxyl functionality participates in coupling at each stage. Resulting analog libraries can be assembled as defined intermediates for SAR workflows, supporting systematic evaluation of backbone and side-chain modifications in amino acid-based molecular scaffolds.

4. Chemical Biology Labeling

Fmoc-L-aspartic acid α-allyl ester can be used in chemical biology research to generate functional amino acid derivatives and peptide conjugation precursors for biomolecule modification strategies. The Fmoc-protected amine supports preparation of peptide conjugates with controlled N-terminus chemistry, while the aspartate side-chain carboxyl group enables conversion into activated intermediates suitable for subsequent coupling to amine-containing targets or for incorporation into linker-bearing constructs. Allyl ester orthogonality can be leveraged to time the exposure of the α-carboxyl functionality during multi-component assembly, supporting selective attachment patterns in labeling workflows. Downstream products may include defined aspartate-containing linkers, peptide tags, or conjugation-ready intermediates used to probe biomolecular interactions with stereochemically consistent acidic residues.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-aspartic acid α-allyl ester is suitable for process chemistry and pharmaceutical intermediate preparation where orthogonally protected amino acid derivatives are required for controlled synthesis of peptide-derived or peptide-like intermediates. The Fmoc carbamate provides a robust N-protection strategy that can be removed under standard deprotection conditions to enable reproducible peptide coupling steps in manufacturing-oriented routes. The allyl ester at the α-carboxyl position supports selective deprotection and conversion into activated acid forms, enabling downstream formation of amide bonds or incorporation into larger fragments with defined regiochemistry. The stereochemically defined L-aspartate core supports consistent intermediate quality for fine chemical synthesis, including the production of aspartyl building blocks used in peptide manufacturing and related industrial chemical production.

6. Analytical Research Standards

Fmoc-L-aspartic acid α-allyl ester can serve as an analytical reference material and derivatization intermediate for method development in amino acid and peptide analysis. The presence of both Fmoc and an allyl ester provides characteristic chemical signatures that can be exploited in chromatographic or spectrometric workflows to monitor protection-state changes, deprotection endpoints, and coupling progress in peptide synthesis analytics. The L-aspartate stereochemistry and carboxyl functionality enable formation of defined derivatives that can be used to validate analytical selectivity for aspartate-containing species. Downstream, the compound can be converted into calibration-relevant protected or activated forms that support quantitative tracking of amino acid derivative transformations in research and industrial quality control contexts.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I